APC, Signal transduction and genetic instability in colorectal cancer

R Fodde, R Smits, H Clevers - Nature reviews cancer, 2001 - nature.com
Colorectal cancer arises through a gradual series of histological changes, each of which is
accompanied by a specific genetic alteration. In general, an intestinal cell needs to comply …

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

PL Welcsh, MC King - Human molecular genetics, 2001 - academic.oup.com
Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose
individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 …

Mismatch repair and DNA damage signalling

L Stojic, R Brun, J Jiricny - DNA repair, 2004 - Elsevier
Postreplicative mismatch repair (MMR) increases the fidelity of DNA replication by up to
three orders of magnitude, through correcting DNA polymerase errors that escaped …

Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage

ES Kandel, J Skeen, N Majewski… - … and cellular biology, 2002 - Taylor & Francis
Activation of Akt, or protein kinase B, is frequently observed in human cancers. Here we
report that Akt activation via overexpression of a constitutively active form or via the loss of …

The role of the BRCA1 tumor suppressor in DNA double-strand break repair

J Zhang, SN Powell - Molecular Cancer Research, 2005 - AACR
The tumor suppressor gene BRCA1 was cloned in 1994 based on its linkage to early-onset
breast and ovarian cancer. Although the BRCA1 protein has been implicated in multiple …

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

SG Brodie, X Xu, W Qiao, WM Li, L Cao, CX Deng - Oncogene, 2001 - nature.com
Germline mutations in the tumor suppressor gene BRCA1 predispose women to breast
cancer, however somatic mutations in the gene are rarely detected in sporadic cancers. To …

[HTML][HTML] BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

A Font, M Taron, JL Gago, C Costa, JJ Sánchez… - Annals of …, 2011 - Elsevier
Background: Neoadjuvant chemotherapy has shown a modest benefit in muscle-invasive
bladder cancer patients; however, the subset of patients most likely to benefit has not been …

BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1–Chk1 pathway, implicating checkpoint dysfunction in microcephaly

SY Lin, R Rai, K Li, ZX Xu… - Proceedings of the …, 2005 - National Acad Sciences
BRIT1 [BRCT-repeat inhibitor of hTERT expression], a repressor of human telomerase
function, is implicated in cellular immortalization. Here, we find that BRIT1 acts as a regulator …

Role of the GH-IGF1 system in progression of cancer

H Werner, Z Laron - Molecular and Cellular Endocrinology, 2020 - Elsevier
Emerging evidence links the growth hormone (GH)-insulin-like growth factor-1 (IGF1)
endocrine axis to cancer development. While this putative correlation is of major …

Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty …

JA Menendez, I Mehmi, E Atlas… - … journal of oncology, 2004 - spandidos-publications.com
A biologically aggressive subset of human breast cancers has been demonstrated to
overexpress fatty acid synthase (FAS), the key enzyme of endogenous FA biosynthesis. This …